Point mutations of CTNNB1 and AXIN1, likely activating the WNT pathway, also were restricted to invasive or metastatic stages (Supplementary Fig. 8) often contributing to genetically heterogeneous subclones within the primary tumor. The gene discussed is AXIN1; the disease is neoplasm.